New Ground-Breaking Treatment for Fibromyalgia Now Available at Harley Street London

TMS has been used for over 20 years to treat a variety of mental health issues. It works by either stimulating or inhibiting specific regions of the brain, helping to return the activity levels of these areas back to normal. At TMS London, they use this technology to target the overactive pain-processing region of people with fibromyalgia, and reduce this activity back to healthy levels, enabling them to help their patients to feel less pain and have an improved quality of life. - October 21, 2021 - Dr. Stephanie Barrett, Consultant Physician and Rheumatologist

Radformation and Aplicaciones Tecnológicas de la Física Launch Automation Partnership at Institut Català d'Oncologia

Radformation, together with their distributor in Spain, Aplicaciones Tecnológicas de la Física, is pleased to announce a partnership with Institut Català d'Oncologia. Institut Català d'Oncologia (ICO) will utilize Radformation’s suite of automation software to... - October 21, 2021 - Radformation

OmeCare and Hillsborough City School District Renew Partnership for Student and Faculty COVID-19 PCR Testing

Partnership helps district ensure safety standards and meet COVID-19 testing protocols for the 2021-2022 school year. - October 16, 2021 - OmeCare

Impact Landscape Survey 2021 Illuminates Global Research Impact Trends

International impact experts, Vertigo Ventures (VV), today announced the release of the Impact Landscape Survey 2021. The report delves into global perspectives on impact, primarily drawn from academics in Australia and the UK, covering areas such as prioritisation of research impact, progress... - October 15, 2021 - Vertigo Ventures

Mary Crowley Cancer Research Welcomes New Chief Executive Officer, Jon Friedenberg

Mary Crowley Cancer Research Welcomes New Chief Executive Officer, Jon Friedenberg

Jon Friedenberg brings a wealth of experience in healthcare leadership to his new appointment as Chief Executive Officer at Mary Crowley Cancer Research. - October 07, 2021 - Mary Crowley Cancer Research

NY Imaging Specialists Brings the Future of Medical Imaging to Nassau County

NY Imaging Specialists Brings the Future of Medical Imaging to Nassau County

NY Imaging Specialists today announced the opening of a brand-new comprehensive imaging center in Nassau County. The center includes advanced imaging technology, a women’s health center, an interventional radiology suite, and an adjoining New York Cancer & Blood Specialists medical... - October 04, 2021 - New York Imaging Specialists

OmeCare and LifeSite Announce COVID-19 Testing Solution Partnership

The partnership provides a turnkey approach for workplaces, schools, major conventions and other group events looking to ensure safety and meet governmental mandates for students, staff, employees and event participants. - October 01, 2021 - OmeCare

“Essentials of Diagnosis, Treatment and Application of Cardiac and Peripheral Vascular Diseases” is About to be Released on Amazon, Barnes & Noble Nook and Apple Books

“Essentials of Diagnosis, Treatment and Application of Cardiac and Peripheral Vascular Diseases” is About to be Released on Amazon, Barnes & Noble Nook and Apple Books

The physical version of the medical research book, “Essentials of Diagnosis, Treatment, and Application of Cardiac and Peripheral Vascular Diseases (Theories, Cases and Analysis)” was published by American Harmony Medical Academic Publisher (AHMAP) on July 26, 2021. - October 01, 2021 - American Harmony Medical Academic Publisher

Launch of TrackImpact.org to Accelerate Global Collaboration Towards a Sustainable Future

International impact experts, Vertigo Ventures (VV), yesterday announced the release of TrackImpact.org, the global research collaboration platform, at the 2021 Impact Symposium. TrackImpact™ is a free-to-access solution that accelerates positive social, economic and environmental impact by... - September 30, 2021 - Vertigo Ventures

Pathologist Creates First Open Source Direct Vision Microscope with an AR Interface - Which You Can Build with a 3D Printer

A UK Pathologist has combined his knowledge of microscopy and 3D printing to develop the world's first direct vision DIY printable advanced microscopy system with features not even seen on the most expensive commercial research microscopes - and has made it all Open Source. The PUMA microscope system is poised to be a game changer in the democratization of microscopy and is totally portable for use in remote field work. See the "PUMA Microscope" YouTube channel for more. - September 27, 2021 - PUMA

Cayman Chemical Receives Grant to Evaluate Use of KMN-159 to Accelerate Dental Implant Osseointegration

The National Institute of Dental and Craniofacial Research has awarded Cayman Chemical with a $1,700,500 grant to explore Cayman’s patented small molecule bone repair agent KMN-159 as the active pharmaceutical ingredient (API) in a drug-device combination to improve the mechanical anchorage... - September 19, 2021 - Cayman Chemical Company

Cayman Chemical Offers Multidisciplinary Lipid-Based Drug Delivery Capabilities

Cayman Chemical, leader in the synthesis, purification and characterization of lipids, has partnered with NanoImaging Services and T&T Scientific to provide a multi-pronged platform that synthesizes, characterizes, and formulates lipid-based nanoparticles to help researchers and pharmaceutical... - September 17, 2021 - Cayman Chemical Company

Scientists at AbboMax, Inc. Developed the New Panels of Monoclonal Antibodies to Study B- and T-Cell Lymphomas

Lymphoma is a malignant transformation of either B or T cells or their subtypes. All lymphoma subtypes combined are the seventh most common cancer in the United States. The B-cell lymphomas are types of lymphoma affecting B cells. About 85% of lymphomas are of B-cell origin. T-cell lymphomas are lymphomas that affect T cells. AbboMax has developed the new panels of monoclonal antibodies to study B- and T-cell lymphomas. - September 03, 2021 - AbboMax, Inc.

Defined Bioscience Licenses FGF2-STAB (G3) for Use in Stem Cell Media

Defined recently concluded a licensing agreement with Czech Republic-based Enantis for global use of Enantis’ patented FGF2-STAB® technology both alone and in stem cell media formulations. FGF2-STAB®, originally coined FGF2-G3, was developed by Enantis and Masaryk University, using... - August 30, 2021 - Defined Bioscience Inc.

Singapore Scientists Dissect RNA Structures of SARS-Cov-2 and Discover Important Host Factor for Infection

A team of researchers from Agency for Science, Technology and Research (A*STAR)’s Genome Institute of Singapore (GIS) and Bioinformatics Institute (BII), together with Duke-NUS Medical School, integrated a variety of technologies to study not only the whole genome of SARS-CoV-2, but also its... - August 27, 2021 - Genome Institute of Singapore

Reverie Psychedelics and Indiana Health Group Partner to Develop World-Class Psychedelic Research Center

Reverie Psychedelics and Indiana Health Group Partner to Develop World-Class Psychedelic Research Center

Reverie Psychedelics (Reverie), a leading and rapidly growing psychedelic – assisted psychotherapy clinic and research organization, has further expanded its footprint and capabilities by partnering with Indiana Health Group (IHG), the largest provider of psychiatric and mental health and... - August 05, 2021 - Reverie Psychedelics

The Cause of Nearsightedness is Explained for the First Time; Work at MIT and Multivision Research Leads to Dr. Medina's Conclusion That Lenses Are the Cause of Myopia

The cause of myopia (nearsightedness) has been unveiled in the article: “The cause of myopia development and progression: Theory, evidence, and treatment” available online as an article-in-press in the scientific journal Survey of Ophthalmology on July 28, 2021. - August 01, 2021 - Antonio Medina

Defined Bioscience Launches with $1.5M SBIR from the NIH to Advance Stem Cell Media

Defined recently received a $1.5M in Phase II SBIR award from the National Institutes of Health to develop defined media over the next two years. - July 03, 2021 - Defined Bioscience Inc.

Pepex Biomedical Receives Approval on a Series of Critical New Patents

Worldwide approval grants the Company exclusivity on a number of methods and manufacturing processes associated with its novel electrochemical biosensors. - July 01, 2021 - Pepex Biomedical, Inc.

Paras Biopharmaceuticals Finland Oy Named as One of the Top Pharma Outsourcing Companies in Europe 2021

Paras Biopharmaceuticals Finland Oy Named as One of the Top Pharma Outsourcing Companies in Europe 2021

Paras Biopharmaceuticals Highlights Company Innovations that Decode and Create Biologics Medicines for Unmet Medical Needs (Pharma Tech Outlook, USA) - June 22, 2021 - Paras Biopharmaceuticals Finland Oy

Targeted Pharmaceuticals and George Mason University Announce First-Ever Preclinical Study Using Cannabinoids in an Organoid Model

Targeted Pharmaceuticals and George Mason University Announce First-Ever Preclinical Study Using Cannabinoids in an Organoid Model

Study Examines the Effects of Cannabinoids Treating Central Nervous System (CNS) Viruses including HIV Associated Dementia - June 16, 2021 - Targeted Pharmaceuticals

Rivkin Center Hires Molly O’Connor as Incoming Executive Director

The Rivkin Center, a Seattle-based nonprofit working to improve women’s health by helping them prevent, detect early and survive ovarian and breast cancer, has hired Molly O’Connor to lead the organization upon the retirement of the current executive director. - June 09, 2021 - Rivkin Center

MedSend and On-Belay Partner to Train African Orthopedic Surgeons

MedSend and On-Belay Partner to Train African Orthopedic Surgeons

On-Belay Medical and MedSend jointly announce their partnership in training national orthopedic surgeons in Africa. On-Belay Medical has committed $125,000 towards MedSend’s five-year residency programs for training national orthopedic surgeons. On-Belay is an innovative medical device... - June 04, 2021 - MedSend

ALS TDI Launches New Young Faces of ALS Program

ALS TDI Launches New Young Faces of ALS Program

The ALS Therapy Development Institute's Young Faces of ALS program spreads awareness about the impact that ALS can have on young people; launch coincides with MLB's inaugural Lou Gehrig Day. - June 02, 2021 - ALS Therapy Development Institute

Solaris Chem Expands Its Distributors Network

Solaris Chem is a company working in the field of fine organic chemistry, synthesizing materials for the organic electronic industry since 2007. His R&D program is mainly focused on the synthesis of custom made semi-conducting polymers, fullerene derivatives and dyes specially formulated for... - May 26, 2021 - Solaris Chem Inc.

Updated Findings of COVID-19 Impact on Biopharmaceutical Industry & CRO Outsourcing Report

2021 Survey Quantifies Current and Expected impact of COVID-19 on Clinical Development and CRO Outsourcing and Changes Since 2020 - May 25, 2021 - Life Science Strategy Group, LLC

Valley Radiology Acquires Philips Ingenuity 128-slice CT/PET

San Diego North County Healthcare Providers and Patients Benefit from Enhanced Imaging Technology provided by Valley Radiology's Acquisition of 128-slice Philips Ingenuity CT/PET. - May 17, 2021 - Valley Radiology

NIDCAP Federation International Releases Videos for Kangaroo Care Awareness Day

NIDCAP Federation International Releases Videos for Kangaroo Care Awareness Day

The NIDCAP Federation International proudly presents a free series of family resource videos available on their website. Produced by The NIDCAP Federation International, and funded by Dräger, the family resource videos are a series of conversations recorded to help support parents who have a premature or medically fragile baby in the hospital. Three new videos have been released in honor of Kangaroo Care Awareness Day. - May 16, 2021 - NIDCAP Federation International

Advanced Silicon Group Closes Seed Preferred Equity Offering and Adds Alan Watson and Sarah Kelly to Board

Advanced Silicon Group, Inc. (ASG), a pioneer in silicon nanotechnology focused on developing novel biosensors, announced today the closing of a $1,020,000 seed preferred stock offering led by Cherrystone Angel Group with participation by MIT Alumni Angels of Northern California, Sidecar Angels and other private investors and the addition of two new Directors, Alan Watson, PhD, MBA and Sarah Kelly, PhD to its Board of Directors. - May 16, 2021 - Advanced Silicon Group

Cayman Develops Powerful, New Multiplex ELISA for Autoantibody Detection

Cayman Chemical's new Q-Plex™ Autoantibody Detection 10-Plex Panel, developed in collaboration with Quansys Biosciences, offers standardized, multiplex capabilities for the concurrent analysis of ten prominent analytes associated with rheumatoid arthritis or other autoimmune diseases. This... - May 16, 2021 - Cayman Chemical Company

EligibilityAdvocates – New Patient Eligibility Service Powered by HealthWare Systems

HealthWare Systems has partnered with a new company, EligibilityAdvocates, which offers patient eligibility and out-of-state Medicaid billing services. The new organization is powered by HealthWare Systems’ revenue cycle technology solutions. EligibilityAdvocates’ on-site patient... - May 06, 2021 - HealthWare Systems

NIDCAP Federation International Releases Episodes 4 & 5 in Podcast Series, NICU Care with NIDCAP

The NIDCAP Federation International proudly presents two new podcast episodes in their series, NICU Care with NIDCAP. Episodes 4 and 5 are now available. Produced by The NIDCAP Federation International, alongside Jeff Bradbury of TeacherCast Educational Network and funded by Jennifer Degl of... - May 03, 2021 - NIDCAP Federation International

Paras Biopharmaceuticals Finland Oy is Named as One of the Top 30 Admired Companies to Watch 2021

Paras Biopharmaceuticals Finland Oy, a fast-growing, biopharmaceutical technology development company, based in Oulu, Finland, announced today that it is named as one of the top 30 admired companies to watch during 2021, by CIO Bulletin, USA. - April 28, 2021 - Paras Biopharmaceuticals Finland Oy

Temperatures Are Rising – It's Time to Check Your Cooling Towers

As Texas and other parts of the country start to heat up, cooling towers will be in full use. Hyperion Biotechnology offers Legionella testing to monitor for bacteria growth to help reduce the risk of spread from cooling towers. - April 21, 2021 - Hyperion Biotechnology, Inc.

The NIDCAP Federation International Releases a Podcast Series Called NICU Care with NIDCAP, Following World NIDCAP Day 2021

The NIDCAP Federation International Releases a Podcast Series Called NICU Care with NIDCAP, Following World NIDCAP Day 2021

The NIDCAP Federation International releases a podcast series called NICU Care With NIDCAP following the celebrations of World NIDCAP Day 2021. In each episode, best practices are discussed to support the health and development of hospitalized newborns, infants and their families, and those that care for them, in intensive care nursery settings and beyond. - April 17, 2021 - NIDCAP Federation International

New Chief Information Security Officer Named at Lifelines Neuro

Rafael Garrido brings cloud security expertise for expansion of Rendr Platform EEG software. - April 15, 2021 - Lifelines Neuro

Y-Biologics & Pierre Fabre: Confirmation of Research Partnership in Oncology

Y-Biologics and Pierre Fabre confirm their research collaboration for the development of new immunotherapies in oncology. - March 31, 2021 - Pierre Fabre

GeneThera, Inc. Wastewater Testing: a Way to Better Control the COVID-19 Pandemic

The global COVID-19 pandemic has demonstrated that neither current systems nor related technologies are capable of preventing or even successfully controlling the spread of zoonotic infectious agents. One of the prominent features of these infectious organisms is their ability to infect both people... - March 30, 2021 - GeneThera Inc.

AbboMax Introduces a Panel of Monoclonal and Polyclonal Anti-Connexin Antibodies

AbboMax introduces a panel of monoclonal and polyclonal anti-connexin antibodies. There are 21 different types of connexins which are known to exist in humans and 20 types in mice. Their abnormal expression and function are associated with human hereditary diseases. AbboMax has been developing & manufacturing high performance immunoassay reagents for many years in California. - March 15, 2021 - AbboMax, Inc.

Zifo RnD Solutions Bags the Fastest Growing Company Award at Deloitte Technology Fast 50 2020

Zifo RnD Solutions has been featuring in this list since 2012 and is the only company in India to have won this award 9 years in a row. - March 15, 2021 - Zifo RnD Solutions

Intrinsic Imaging Undergoes Third FDA Inspection with No 483 Observations

Intrinsic Imaging recently underwent an extensive inspection by the U.S. Food and Drug Administration (FDA). The FDA determined Intrinsic Imaging was in complete compliance with all federal regulations and the company received zero 483 observations. This was Intrinsic Imaging's third FDA inspection and its third inspection with no findings. - March 01, 2021 - Intrinsic Imaging, LLC

AbboMax is Pleased to Introduce the Collection of Monoclonal and Polyclonal Anti-STAT Antibodies

STAT proteins (Signal transducers and activators of transcription) are cytoplasmic transcription factors that play an essential role in transmitting signals from the cellular membrane to the nucleus. Misregulation of STAT pathway frequently leads to tumorogenesis. AbboMax introduces a panel of monoclonal and polyclonal anti-STAT antibodies. - February 27, 2021 - AbboMax, Inc.

Paras Biopharmaceuticals Finland Oy Affordable Healthcare Efforts Viewed in Over 90 Countries: Biosimilar Technologies Get Attention

Paras Biopharmaceuticals Finland Oy Affordable Healthcare Efforts Viewed in Over 90 Countries: Biosimilar Technologies Get Attention

Paras Biopharmaceuticals Finland Oy (Paras Biopharma) is a Finland-based microbial biologics company which focuses on the development of technologies for biosimilars and biologics in an efficient manner. The overall objective of Paras Biopharma is to enable economical production and future availability of affordable medicines for unmet medical needs. - February 17, 2021 - Paras Biopharmaceuticals Finland Oy

Phase One Development of Rapid COVID-19 Point of Care Test Complete

Phase One Development of Rapid COVID-19 Point of Care Test Complete

Pepex Biomedical has effectively concluded first stage development efforts including successfully demonstrating working chemistry and manufacturing functionality of its existing electrochemical biosensor. - February 11, 2021 - Pepex Biomedical, Inc.

Collection Services Provide Peace of Mind in Fight Against Legionella Bacteria

Hyperion Biotechnology expands Legionella water collection services in several California cities and other U.S. locations. Facility owners can schedule services to support their water safety plans. - February 11, 2021 - Hyperion Biotechnology, Inc.

Cayman Adds Nordic BioSite as Trusted Distributor

Cayman Chemical’s complete assay kit, protein, antibody, and biochemical portfolio is now more accessible to Denmark, Finland, Iceland, Norway, Sweden, and the Baltic countries as well as Russia through a distribution agreement with Nordic BioSite. Headquartered in Täby, Sweden, Nordic... - February 10, 2021 - Cayman Chemical Company

14 New Monoclonal Anti-Cytokeratin Antibodies from AbboMax

AbboMax adds over a dozen new anti-cytokeratin monoclonal antibodies to its inventory. Cytokeratins are proteins found in epithelium. A variety of cytokeratins can be used for subtyping various forms of epithelial differentiation or for the detection of possible sites of origin of tumors. Primary tumors usually recapitulate the cytokeratin profiles of the cells from which they are derived. They are one of the most effective epithelial differentiation and tumor markers. - January 13, 2021 - AbboMax, Inc.

A Novel Treatment Modality for COVID-19: Global Cancer Technology is Developing a Nanoparticle Which May Selectively Target, Bind and Inactivate Coronavirus Virions

A Novel Treatment Modality for COVID-19: Global Cancer Technology is Developing a Nanoparticle Which May Selectively Target, Bind and Inactivate Coronavirus Virions

Global Cancer Technology, an emerging biopharmaceutical company, is developing a novel treatment modality to selectively kill the COVID-19 virus. - December 30, 2020 - Global Cancer Technology

How COVID-19 Has Impacted Academic Research

Dr. Peter Mallow, director, health economics and clinical outcomes research and assistant professor at Xavier University, shares his thoughts on the effect of COVID-19 on the health research community. - November 30, 2020 - Journal of Health Economics and Outcomes Research

Unique New Device to Self-Monitor COVID-19 Risk During Delay Between Tests, from Centers for Age Control Inc.

Unique New Device to Self-Monitor COVID-19 Risk During Delay Between Tests, from Centers for Age Control Inc.

Few people are able to take a COVID-19 test every day or even every week or month. A negative result can be useful on the day of the test, but a person will not know if infected later. The COVID-19 HealthMeter™ reduces that risk with daily noninvasive physiological self-monitoring of 16 COVID-19 indicators and risk factors, including functional age vs. birth age, high frequency hearing loss, mental confusion, short term memory, lungs, blood oxygen, heart rate, blood pressure, body fat, etc. - November 12, 2020 - Centers for Age Control Inc.

Press Releases 1 - 50 of 2,154